CD4 and neoplasm: Topical administration in the mice depleted CD4+ T and CD8+ T cells in the peripheral blood circulation, redistributed them in mouse CLNs and brain, and reversed tumor immune suppression by significantly reducing the absolute number of Tregs in the tumor microenvironment.